Type 2 diabetes mellitus (T2DM), characterized by chronic hyperglycemia resulted from resistance against insulin, is the most prevalent metabolic disorder worldwide, and it currently affects over 300 million people all over the world (American Diabetes Association, 2014; Zheng, Ley, & Hu, 2018). This evidence concerns the gene INS and type 2 diabetes mellitus.